Precision Functional Brain Mapping in Psilocybin (Psilocybin PFM)
Precision Functional Brain Mapping to Understand the Mechanisms of Psilocybin
Sponsor: Washington University School of Medicine
This EARLY_PHASE1 trial investigates Psilocybin and is currently completed. Washington University School of Medicine leads this study, which shows 11 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Nov 2025 — Present [monthly]
Completed EARLY_PHASE1
-
Sep 2025 — Nov 2025 [monthly]
Completed EARLY_PHASE1
-
Dec 2024 — Sep 2025 [monthly]
Completed EARLY_PHASE1
Status: Active Not Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
▶ Show 6 earlier versions
-
Dec 2022 — Jul 2024 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jul 2022 — Dec 2022 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Jan 2022 — Jul 2022 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Jan 2022 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .